Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evolution Research Group (ERG) is a leading independent clinical research site network in the United States, specializing in complex trials for the central nervous system (CNS) and other specialized therapeutic areas. The company operates a large portfolio of owned and affiliated clinical research sites, providing comprehensive Phase I-IV study capabilities to pharmaceutical and biotechnology sponsors. ERG is particularly recognized for its expertise in psychiatry, neurology, and pain management, as well as its ability to conduct highly controlled inpatient studies. By leveraging a centralized recruitment and quality oversight model, the group accelerates the development of novel therapies through efficient patient enrollment and high-quality data collection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evolution Group.